2009Chinese Journal of PharmaceuticsRequires access

Preparation of diflunisal sustained release tablets

HE Zhong-gui

Open publisher page 0 citations

Abstract

Objective To prepare diflunisa1 sustained release tablets and optimize the formulation by evaluating the effect of different excipients.Methods An in vitro analytical method was established.Factors influencing the in vitro release of diflunisa1 from sustained release tablets were investigated.Results Both formulation parameters(the viscosity and amount of HPMC, the amount of lactose and different sorts of binders) and manufacture techniques(wet granulation versus direct compression, compression pressure and particle size of the raw material) affected the in-vitro release of diflunisa1 from sustained release tablets.Conclusions Sustained release diflunisa1 tablet could be prepared with appropriate release profile.

About this research paper

What this paper is about

Objective To prepare diflunisa1 sustained release tablets and optimize the formulation by evaluating the effect of different excipients.Methods An in vitro analytical method was established.Factors influencing the in vitro release of diflunisa1 from sustained release tablets were investigated.Results Both formulation parameters(the viscosity and amount of HPMC, the amount of lactose and different sorts of binders) and manufacture techniques(wet granulation versus direct compression, compression pressure and particle size of the raw material) affected the in-vitro release of diflunisa1 from sustained release tablets.Conclusions Sustained release diflunisa1 tablet could be prepared with appropriate release profile.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To prepare diflunisa1 sustained release tablets and optimize the formulation by evaluating the effect of different excipients.Methods An in vitro analytical method was established.Factors influencing the in vitro release of diflunisa1 from sustained release tablets were investigated.Results Both formulation parameters(the viscosity and amount of HPMC, the amount of lactose and different sorts of binders) and manufacture techniques(wet granulation versus direct compression, compression pressure and particle size of the raw material) affected the in-vitro release of diflunisa1 from sustained release tablets.Conclusions Sustained release diflunisa1 tablet could be prepared with appropriate release profile.

Key concepts: Pharmaceutics, Granulation, Diflunisal, Chromatography, Particle size, Chemistry, Viscosity, Lactose

Related papers

Back to paper searchBrowse research topicsOriginal source
Preparation of diflunisal sustained release tablets — Research Paper | ScholarLens